About the
NeLM
|
Help & Support
|
Site Feedback
|
Update Newsletter Subscription
Homepage
Login
|
Register
Search the NeLM
Medicines A-Z
Find key information about medicines by name (prototype)
Browse by Categories:
BNF Category
|
Medical Specialty
|
National Health Service
|
Medicines Information
Browse by NeLM area:
Evidence
|
Other Library Updates
|
News
|
Health In Focus
|
Medicines A-Z
|
Communities
|
Useful Links
|
Formularies
Medical Specialty
Anaesthesia
Bone Diseases
Cardiovascular Medicine
Care of Older People
Cerebrovascular Disorders
Complementary Medicine
Dentistry
Dermatology
Ear, Nose and Throat (ENT) disorders
Emergency Medicine
Endocrinology
Family planning
Gastroenterology
Geriatric Medicine
Haematology
Immunology and vaccination
Infections
Infectious Diseases
Intensive Care (ICU)
Liver disease
Menopause / hormone replacement therapy (HRT)
Mental Health
Neurology
Nutrition and Metabolism
Obstetrics & Gynaecology
Oncology
Ophthalmology
Paediatrics
Pain control
Palliative care
Preventative medicines
Radiology
Renal medicine
Reproductive medicine
Respiratory Medicine
Rheumatology
Sports medicine
Surgery
Travel medicine
Urology
Wound Management
Ankylosing spondylitis
Connective tissue disease
Gout
Musculoskeletal syndromes (including chronic fatigue and Gulf war syndromes)
Osteoarthritis
Osteoporosis
Rheumatoid Arthritis
Systemic Lupus Erythematosus
324 library items
in Osteoporosis
Filter results by:
Date Published
2012 (3)
2011 (37)
2010 (46)
2009 (40)
2008 (63)
More
NeLM
Area
News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies
Results filtered by:
Category
Rheumatology (
remove
)
,
Osteoporosis (
remove
)
Sort by:
Least recent publication date
Most recent publication date
Title alphabetical A-Z
Title alphabetical Z-A
Source alphabetical A-Z
Source alphabetical Z-A
Display summary:
No
Yes
Results 1 - 10 of 324
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next
1.
NICE issues draft guideline on assessing risk of fragility fracture in osteoporosis
Source:
NICE
,
Date published:
09/02/2012
Category:
Clinical guidelines
|
National Institute of Clinical Excellence (NICE)
|
Osteoporosis
NeLM
Area:
News
Link
2.
Prospective cohort study evaluates association between PPI use and risk of hip fracture in postmenopausal women
Source:
BMJ
,
Date published:
01/02/2012
Category:
1.3.5 Proton pump inhibitors
|
Adverse Drug Reactions
|
Osteoporosis
NeLM
Area:
News
Link (free full text at the time of posting)
BBC Health report
RPS press release
NHS Choices assessment
3.
DTB reviews denosumab for postmenopausal osteoporosis
Source:
Drug and Therapeutics Bulletin
,
Date published:
13/01/2012
Category:
6.6.2 Bisphosphonates and other drugs affecting bone metabolism
|
Drug reviews
|
Osteoporosis
NeLM
Area:
Evidence
>
Drug Specific Reviews
Link (abstract)
4.
Bisphosphonates for osteoporosis in primary biliary cirrhosis
Source:
Cochrane Library
,
Date published:
28/12/2011
Category:
6.6.2 Bisphosphonates and other drugs affecting bone metabolism
|
Drug reviews
|
Osteoporosis
NeLM
Area:
Evidence
>
Drug Class Focused Reviews
Link to Abstract
5.
Fultium-D3 (colecalciferol) capsules approved by MHRA and due for launch in January 2012
Source:
Personal communication
,
Date published:
30/11/2011
Category:
9.6.4 Vitamin D
|
Horizon scanning
|
Nutrition and Metabolism
|
Osteoporosis
NeLM
Area:
News
Link to SPC
6.
Draft Quality Standard for hip fracture published for consultation by NICE
Source:
NICE
,
Date published:
03/11/2011
Category:
Bone Diseases
|
National Institute of Clinical Excellence (NICE)
|
Orthopaedic
|
Osteoporosis
NeLM
Area:
News
Draft Quality Standard
7.
Final results from Z-FAST study evaluating zoledronic acid in women with breast cancer taking adjuvant letrozole
Source:
Cancer
,
Date published:
17/10/2011
Category:
6.6.2 Bisphosphonates and other drugs affecting bone metabolism
|
8.3.4 Hormone antagonists
|
Adverse Drug Reactions
|
Cancer: breast
|
Osteoporosis
NeLM
Area:
News
Link (abstract)
Interim results (abstract)
8.
MHRA Drug Safety Update (October 2011): Calcium and vitamin D: studies of cardiovascular risk do not support prescribing changes
Source:
MHRA
,
Date published:
13/10/2011
Category:
9.5.5 Selenium
|
9.6.4 Vitamin D
|
Adverse Drug Reactions
|
Cardiovascular Medicine
|
Information provision
|
Medicines and Healthcare products Regulatory Agency (MHRA)
|
Nutrition and Metabolism
|
Osteoporosis
|
Prescribing and supply of medicines
NeLM
Area:
Evidence
>
Medication Safety
Link
9.
US FDA approves denosumab for cancer therapy-induced bone loss in women with breast cancer and men with prostate cancer
Source:
BioSpace.com
,
Date published:
20/09/2011
Category:
6.6.2 Bisphosphonates and other drugs affecting bone metabolism
|
Food &Drug Administration (FDA)
|
Licence extension
|
Ophthalmology
|
Osteoporosis
NeLM
Area:
News
Link
10.
FDA committee debates recommended duration of bisphosphonate therapy
Source:
Reuters , PharmaTimes, DIA daily
,
Date published:
12/09/2011
Category:
6.6.2 Bisphosphonates and other drugs affecting bone metabolism
|
Adverse Drug Reactions
|
Osteoporosis
NeLM
Area:
News
Link to Reuters (subscribers only)
Link to PharmaTimes (free subscription required)
Link to DIA Daily
Results 1 - 10 of 324
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next